M. Yun

发表

5-Lipoxygenase plays an essential role in 4-HNE-enhanced ROS production in murine macrophages via activation of NADPH oxidase

C. Kim, K. Seo, Hye-Mi Park, 2010, Free radical research.

Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production.

C. Kim, K. Seo, Hye-Mi Park, 2009, The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology.

The action mode of lysophosphatidylcholine in human monocytes.

D. Im, F. Okajima, M. Yun, 2004, Journal of pharmacological sciences.

Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition

H. Kim, B. Cho, Z. Zheng, 2017, Oncogene.

Mouse–human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

Jae Woo Choi, S. Paik, B. Cho, 2020, British Journal of Cancer.

Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway.

J. Y. Kim, Hyun-Young Park, J. Park, 2011, Biochimica et biophysica acta.

Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma

S. Paik, M. Ahn, B. Cho, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Enhancer Remodeling and MicroRNA Alterations Are Associated with Acquired Resistance to ALK Inhibitors.

You Won Lee, Jae Woo Choi, J. Shih, 2018, Cancer research.

Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells.

J. Y. Lee, C. Kim, S. Bae, 2007, Life sciences.

Participation of 5-lipoxygenase-derived LTB(4) in 4-hydroxynonenal-enhanced MMP-2 production in vascular smooth muscle cells.

C. Kim, S. Bae, K. Seo, 2010, Atherosclerosis.

4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species.

J. Y. Lee, C. Kim, S. Bae, 2006, Toxicology letters.

DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor–resistant lung cancer therapy

Mirang Kim, Jeong-Hwan Kim, Seon-Young Kim, 2022, Experimental & Molecular Medicine.

4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways.

C. Kim, S. Bae, K. Seo, 2008, Free radical biology & medicine.

Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/Akt signaling pathway.

J. Y. Lee, C. Kim, S. Bae, 2006, Pharmacological research.

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung Cancer

You Won Lee, Sung Sook Lee, A. Drilon, 2020, Clinical Cancer Research.

Structure-activity relationship of lysophosphatidylcholines in HL-60 human leukemia cells.

Jee H Jung, D. Im, Wei-Hong Wang, 2004, Acta pharmacologica Sinica.

4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK.

C. Kim, S. Bae, K. Seo, 2010, Toxicology and applied pharmacology.

Gomisin A from Schisandra chinensis induces endothelium-dependent and direct relaxation in rat thoracic aorta.

C. Kim, S. Bae, K. Seo, 2007, Planta medica.

Clinical decision support algorithm based on machine learning to assess the clinical response to anti-programmed death-1 therapy in patients with non-small-cell lung cancer.

S. Heo, S. Lim, B. Cho, 2021, European journal of cancer.

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer

Min Hwan Kim, You Won Lee, Jae Woo Choi, 2019, EMBO molecular medicine.

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.

S. Heo, S. Lim, B. Cho, 2020, Cancer discovery.

Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK-positive non-small-cell lung cancer

S. Lim, B. Cho, H. Shim, 2020, Journal for ImmunoTherapy of Cancer.

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer

Ho-Juhn Song, Soyoung Kim, B. Cho, 2019, Clinical Cancer Research.

ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma

B. Cho, S. Yoon, M. Hong, 2018, Oncogene.

Profiling of protein–protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors

B. Cho, S. Im, Junho Chung, 2018, Nature Biomedical Engineering.

Involvement of NAD(P)H oxidase in the enhanced expression of cell adhesion molecules in the aorta of diabetic mice.

C. Kim, M. Yun, D. S. Im, 2004, Life sciences.

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

S. Heo, S. Lim, B. Cho, 2022, Therapeutic advances in medical oncology.

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

S. Heo, S. Lim, B. Cho, 2021, Clinical Cancer Research.

Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation

B. Cho, Joo‐Hang Kim, Sun Mi Kim, 2013, Molecular Cancer Therapeutics.

Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.

Jae Woo Choi, S. Paik, B. Cho, 2018, Lung cancer.

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma

S. Heo, B. Cho, H. Kim, 2019, Scientific Reports.

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

Jae Woo Choi, S. Paik, S. Lim, 2020, BMC Cancer.

Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and / or Metastatic Squamous Cell Carcinoma of Head and Neck

Min Goo Lee, S. Paik, M. Ahn, 2015 .

Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

Min Goo Lee, S. Paik, M. Ahn, 2014, Clinical Cancer Research.

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

Jae Woo Choi, S. Paik, S. Lim, 2020, BMC Cancer.

Establishment of a Conditional Transgenic Mouse Model Recapitulating EML4‐ALK–Positive Human Non–Small Cell Lung Cancer

Sang Gyun Kim, S. Lim, B. Cho, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma

S. Paik, S. Lim, B. Cho, 2015, Molecular Cancer Therapeutics.

4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase.

C. Kim, S. Bae, Hye-Mi Park, 2009, Free radical biology & medicine.

Tyrosine kinase-mediated activation of NADPH oxidase enhances proliferative capacity of diabetic vascular smooth muscle cells.

C. Kim, Y. K. Kim, S. Son, 2005, Life sciences.

EGFR-Mediated Reactivation of MAPK Signaling Induces Acquired Resistance to GSK2118436 in BRAF V600E–Mutant NSCLC Cell Lines

Min Hwan Kim, S. Paik, S. Lim, 2016, Molecular Cancer Therapeutics.

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity

S. Heo, S. Lim, June-Dong Park, 2022, Frontiers in Oncology.

Clinical trials outcomes of combined BKM120 and cetuximab compared to BKM120 in recurrent and/or metastatic squamous cell carcinoma of head and neck (R/M-SCCHN).

S. Paik, M. Ahn, S. Lim, 2015 .